Simply in the previous years, researchers have recognized the huge function that the microbes living inside and on us play in our health. The human microbiome, and particularly the gut microbiome, has been connected to numerous chronic diseases, including diabetes. An unbalanced microbiome composition has been discovered in clients with diabetes, who tend to have a less diverse gut microbiome as compared to healthy people. Specs.
Some business are developing diabetes treatments targeting the microbiome. The French Valviotis is presently performing preclinical testing of a drug targeted at increasing the microbiome variety as a treatment for type 2 diabetes. Although promising, the microbiome field is extremely young and its complexity makes it tough to develop causation after finding correlation.
That world might not be up until now away, as lots of companies are developing non-invasive techniques to substitute finger pricking. Specs. Stability Applications has actually established a device called GlucoTrack that can determine glucose utilizing electro-magnetic waves and is currently readily available in Europe. Similar innovations are turning up, with GlucoSense in London using laser light to determine sugar levels and MediWise utilizing radio waves.
The GlucoWise sensing unit prototypePatches are also ending up being a popular form of determining blood glucose without needles, such as FreeStyle Libre, an inch-wide patch that can be worn for up to 2 weeks. At the University of Bath, scientists are developing a graphene patch that could provide higher accuracy by measuring sugar levels individually in multiple hair follicles – Specs.
On the other hand, Senseonic and Roche are working on a gadget that is implanted under the skin. Specs. Still, non-invasive alternatives to determine blood sugar level often deal with problems regarding precision. The popular glucose-measuring contact lens that Google revealed in 2014 was dismissed as “technically infeasible” and further developments will be needed to reach the degree of precision of finger-pricking techniques.
Researchers are already speculating about microchips that can diagnose diabetes type 1 before the signs appear or nanorobots traveling in the bloodstream while they determine glucose and provide insulin – Specs.”There’s little fiction left in this. I strongly believe that microrobotics will come and will belong to our drug shipment within the next 10 years,” stated Tomas Landh, Director of Technique and Development Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Annual MeetingWhatever the future brings, it will undoubtedly make a big difference in the lives of millions of people worldwide.